U.S. patent application number 15/633582 was filed with the patent office on 2017-12-14 for compositions for use with a fascia tissue treatment device to reduce cellulite.
The applicant listed for this patent is Ashley Diana Black International Holdings, LLC. Invention is credited to Ashley D. Black.
Application Number | 20170354591 15/633582 |
Document ID | / |
Family ID | 59069483 |
Filed Date | 2017-12-14 |
United States Patent
Application |
20170354591 |
Kind Code |
A1 |
Black; Ashley D. |
December 14, 2017 |
COMPOSITIONS FOR USE WITH A FASCIA TISSUE TREATMENT DEVICE TO
REDUCE CELLULITE
Abstract
Compositions for lubricating skin during application of a fascia
tissue treatment device, thereby reducing the appearance of
cellulite in skin and methods of forming such compositions.
Inventors: |
Black; Ashley D.; (Pearland,
TX) |
|
Applicant: |
Name |
City |
State |
Country |
Type |
Ashley Diana Black International Holdings, LLC |
Pearland |
TX |
US |
|
|
Family ID: |
59069483 |
Appl. No.: |
15/633582 |
Filed: |
June 26, 2017 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
15182239 |
Jun 14, 2016 |
9687441 |
|
|
15633582 |
|
|
|
|
Current U.S.
Class: |
1/1 |
Current CPC
Class: |
A61K 8/99 20130101; A61Q
19/06 20130101; A61K 8/987 20130101; A61K 8/11 20130101; A61K
8/9789 20170801; A61K 8/678 20130101; A61K 8/9794 20170801; A61K
2800/5922 20130101; A61K 8/347 20130101; A61K 8/375 20130101; A61K
8/922 20130101; A61K 8/92 20130101 |
International
Class: |
A61K 8/98 20060101
A61K008/98; A61K 8/97 20060101 A61K008/97; A61K 8/37 20060101
A61K008/37; A61K 8/67 20060101 A61K008/67; A61Q 19/06 20060101
A61Q019/06; A61K 8/92 20060101 A61K008/92; A61K 8/34 20060101
A61K008/34; A61K 8/11 20060101 A61K008/11 |
Claims
1. A composition comprising oil, caprylic/capric triglyceride,
plankton extract, tocopherol, and fragrance, further wherein the
oil is from about 80.0% to about 95.0%, the caprylic/capric
triglyceride is from about 5.0% to about 10.0%, the plankton
extract is from about 0.01% to about 0.09%, the tocopherol is from
about 0.01% to about 0.09%, and the fragrance is from about 0.1% to
about 0.9% of the total weight by volume of the composition.
2. The composition of claim 1, further comprising rice bran
extract, wherein the rice bran extract is from about 1.0% to about
4.0% of the total weight by volume of the composition.
3. The composition of claim 1, further comprising soybean seed oil,
wherein the soybean seed oil is from about 0.1% to about 0.9% of
the total weight by volume of the composition.
4. The composition of claim 1, further comprising lavender oil,
wherein the lavender oil is from about 0.1% to about 0.9% of the
total weight by volume of the composition.
5. The composition of claim 1, further comprising caprylyl glycol,
wherein the caprylyl glycol is from about 0.1% to about 0.9% of the
total weight by volume of the composition.
6. The composition of claim 1, further comprising
ethylhexylglycerin, wherein the ethylhexylglycerin is from about
0.1% to about 0.9% of the total weight by volume of the
composition.
7. The composition of claim 1, further comprising hexylene glycol,
wherein the hexylene glycol is from about 0.1% to about 0.9% of the
total weight by volume of the composition.
8. The composition of claim 1, further comprising phenoxyethanol,
wherein the phenoxyethanol is from about 0.1% to about 0.9% of the
total weight by volume of the composition.
9. The composition of claim 1, further comprising an
antioxidant.
10. The composition of claim 1, further comprising an antibacterial
agent.
11. The composition of claim 1, further comprising an antifungal
agent.
12. The composition of claim 1, further comprising a moisturizing
agent.
13. The composition of claim 1, further comprising an
emulsifier.
14. The composition according to claim 1, wherein the composition
is encapsulated.
15. The composition according to claim 1, wherein the composition
is in the form of an emulsion.
16. The composition according to claim 1, wherein the composition
is in the form of a cream.
17. The composition according to claim 1, wherein the composition
is in the form of a lotion.
18. The composition according to claim 1, wherein the composition
is in the form of a gel.
19. The composition according to claim 1, wherein the composition
is in the form of an oil.
Description
RELATED APPLICATIONS
[0001] This Application is a continuation of U.S. Non-Provisional
Application Ser. No. 15/182,239, filed Jun. 14, 2016, entitled
COMPOSITIONS FOR USE WITH A FASCIA TISSUE TREATMENT DEVICE TO
REDUCE CELLULITE, the contents of which are hereby incorporated by
reference in their entirety.
FIELD OF THE INVENTION
[0002] The principles of the present invention relate generally to
compositions, and methods of forming such compositions, for topical
application to the skin which comprise various plant extracts and
the use of such compositions to provide benefits to the skin, in
particular, lubrication for fascial release with a fascia tissue
treatment device producing aesthetic improvement and/or
anti-cellulite benefits.
BACKGROUND OF THE INVENTION
[0003] Fascia is a layer of fibrous connective tissue beneath the
skin that attaches, stabilizes, encloses, separates muscles and
other internal organs, and performs other functions. The tissue
allows for proper functioning of muscles with respect to one
another and nerve communications, among other dynamic operations.
When fascia tissue becomes damaged by injury, tissue knots, or
other medical reasons, it can take time to correct itself.
Alternatively, fascia distortions of all types can be repaired by
direct manipulation, such as fascial release and/or therapy, to
allow for proper functioning of the tissue and allow the underlying
muscle as well as other bodily functions to properly operate. In
some cases, damaged fascia can be repaired without much difficulty,
while in other cases, restoring fascia to its proper form can take
considerably more effort. Other reasons for treating fascia include
cosmetic reasons, including people who have dimpled skin, fatty,
saggy skin, and circulatory problems, for example. Fascia, when
properly treated, can considerably reduce the dimples in skin
caused by cellulite, as well as many other cosmetic benefits to the
skin and shape of the body.
[0004] Cellulite is the herniation of subcutaneous fat within
fibrous connective tissue that manifests topographically as skin
dimpling and nodularity, often, but not limited to, in the
buttocks, thighs, and abdomen. Excess fat accumulation increases
the volume of adipocytes, which bulge into a weakened dermis to
create the characteristic irregularities in the appearance of the
epidermal surface. A number of factors can cause cellulite
including, for example, genetics, hormones, and lifestyle. Dieting
to decrease fat intake, exercising to increase fat metabolism and
prevent the build up of cellulite, and fascial release and
hydrotherapy to stimulate lymphatic drainage can help reduce the
appearance of cellulite. However, these means for combating
cellulite or subcutaneous fat are limited, and the need remains for
additional approaches. The protrusion of enlarged fat tissue into
the dermis is one of the major factors contributing to the
appearance of cellulite. One of the approaches to reduce cellulite
is to stimulate fat breakdown and reduce the amount of fat and/or
lipids in the adipocytes, or fat cells. There is active interest in
the cosmetics industry in developing products that may be applied
topically to the skin to counteract adverse changes in the skin,
such as cellulite, saggy skin, fatty and uneven texture. As a
result, cosmetic products that reverse or forestall such changes
are increasingly in demand. Consumers continually seek to improve
the appearance of skin affected by unwanted deposition and/or
accumulation of fat, including cellulite and other issues.
BRIEF SUMMARY OF THE INVENTION
[0005] In combination, a fascia tissue treatment device lubricated
with an oil composition to reduce cellulite can significantly
improve skin aesthetic appearance and would be advantageous in the
formulation of treatments, products, and protocols for the skin. As
described herein, innovative and useful compositions for use as a
lubricant with a fascia tissue treatment device for the treatment
of cellulite and the like are provided along with methods for
forming such compositions.
[0006] One aspect of the present disclosure is the provision of
compositions for reducing cellulite and lubricating skin during
treatment with a fascia tissue treatment device. In one embodiment,
the composition comprises sunflower seed oil. In another
embodiment, the composition comprises caprylic/capric triglyceride.
In yet another embodiment, the composition comprises rice bran
extract. In still another embodiment, the composition comprises
plankton extract. In other embodiments, the composition comprises
rosemary leaf extract. In yet other embodiments, the composition
comprises sunflower extract. In some embodiments, the composition
comprises tocopherol. In particular embodiments, the composition
comprises isopropyl myristate. In certain embodiments, the
composition comprises soybean seed oil. In one embodiment, the
composition comprises lavender oil. In another embodiment, the
composition comprises lavendin oil. In yet another embodiment, the
composition comprises phenoxyethanol. In still another embodiment,
the composition comprises caprylyl glycol. In other embodiments,
the composition comprises ethylhexylglycerin. In yet other
embodiments, the composition comprises hexylene glycol. In some
embodiments, the composition comprises fragrance.
[0007] In certain embodiments, the sunflower seed oil, sunflower
extract, or both are from Helianthus annuus. In one embodiment, the
rice bran extract is from Oryza sativa. In another embodiment, the
rosemary leaf extract is from Rosmarinus officinalis. In still
another embodiment, the soybean seen oil is from Glycine soja. In
other embodiments, the lavender oil is from Lavandula angustifolia.
In some embodiments, the lavendin oil is from Lavandula
hydrida.
[0008] In particular embodiments, the seed oil can be from about
80%, about 81%, about 82%, about 83%, about 84%, about 85%, about
86%, about 87%, about 88%, about 89%, about 90%, about 91%, about
92%, about 93%, about 94%, or about 95% of the total weight by
volume of the composition. In certain embodiments, the
caprylic/capric triglyceride can be from about 5.0%, about 5.5%,
about 6.0%, about 6.5%, about 7.0%, about 7.5%, about 8.0%, about
8.5%, about 9.0%, about 9.5%, or about 10.0% of the total weight by
volume of the composition. In one embodiment, the rice bran extract
can be from about 1.0%, about 1.5%, about 2.0%, about 2.5%, about
3.0%, about 3.5%, or about 4.0% of the total weight by volume of
the composition. In another embodiment, the plankton extract can be
from about 0.01%, about 0.02%, about 0.03%, about 0.04%, about
0.05%, about 0.06%, about 0.07%, about 0.08%, or about 0.09% of the
total weight by volume of the composition. In yet another
embodiment, the rosemary leaf extract can be from about 0.01%,
about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%,
about 0.07%, about 0.08%, or about 0.09% of the total weight by
volume of the composition. In still another embodiment, the
sunflower extract can be from about 0.1%, about 0.2%, about 0.3%,
about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or
about 0.9% of the total weight by volume of the composition. In
other embodiments, the tocopherol can be from about 0.01%, about
0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about
0.07%, about 0.08%, or about 0.09% of the total weight by volume of
the composition. In yet other embodiments, the isopropyl myristate
can be from about 0.1%, about 0.2%, about 0.3%, about 0.4%, about
0.5%, about 0.6%, about 0.7%, about 0.8%, or about 0.9% of the
total weight by volume of the composition. In some embodiments, the
soybean seed oil can be from about 0.1%, about 0.2%, about 0.3%,
about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or
about 0.9% of the total weight by volume of the composition. In
particular embodiments, the lavender oil can be from about 0.01%,
about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%,
about 0.07%, about 0.08%, or about 0.09% of the total weight by
volume of the composition. In certain embodiments, the lavendin oil
can be from about 0.01%, about 0.02%, about 0.03%, about 0.04%,
about 0.05%, about 0.06%, about 0.07%, about 0.08%, or about 0.09%
of the total weight by volume of the composition. In one
embodiment, the phenoxyethanol can be from about 0.1%, about 0.2%,
about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about
0.8%, or about 0.9% of the total weight by volume of the
composition. In another embodiment, the caprylyl glycol can be from
about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about
0.6%, about 0.7%, about 0.8%, or about 0.9% of the total weight by
volume of the composition. In yet another embodiment, the
ethylhexylglycerin can be from about 0.01%, about 0.02%, about
0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about
0.08%, or about 0.09% of the total weight by volume of the
composition. In still another embodiment, the hexylene glycol can
be from about 0.01%, about 0.02%, about 0.03%, about 0.04%, about
0.05%, about 0.06%, about 0.07%, about 0.08%, or about 0.09% of the
total weight by volume of the composition. In other embodiments,
the fragrance can be from about 0.1%, about 0.2%, about 0.3%, about
0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, or about 0.9%
of the total weight by volume of the composition. Comparable
percentages may be provided for by volume of the total composition.
A person of ordinary skill in the art would understand that the
concentrations can vary depending on the addition, substitution,
and/or subtraction of ingredients in a given composition.
[0009] In some embodiments, the composition can be stored in a
dispenser for spray or other dispensing method. In one embodiment,
the dispenser can be integrated into or onto the fascia tissue
treatment device. Alternatively, the dispenser may be external from
the fascia tissue treatment device. In an alternative embodiment,
the dispenser can include a member that functions to dispense the
composition in a roll-on, sponge applicator, spray squirt device,
or other dispensing technique. A cartridge that includes the
composition can be used and positioned within a dispensing
mechanism of the fascia tissue treatment device. In particular
embodiments, the composition can be applied from a dispenser. In
certain embodiments, the dispenser comprises a spray mechanism.
[0010] Another aspect of the present disclosure is the provision of
a method of forming a composition for reducing cellulite and other
skin discrepancies, such as fat pockets, skin texture, spider
veins, varicose veins, poor circulation and related issues, rashes,
and lubricating skin during treatment with a fascia tissue
treatment device. In one embodiment, the method comprises mixing
sunflower seed oil, caprylic/capric triglyceride, rice bran
extract, plankton extract, rosemary leaf extract, sunflower
extract, tocopherol, isopropyl myristate, soybean seed oil,
lavender oil, lavendin oil, phenoxyethanol, caprylyl glycol,
ethylhexylglycerin, hexylene glycol, fragrance, or any combination
thereof.
DETAILED DESCRIPTION OF THE INVENTION
[0011] A combination of ingredients have been found to
synergistically reduce cellulite and improve other beauty
conditions over a period of time. Treatment with a fascia tissue
treatment device can produce better results of certain conditions,
such as, but not limited to, reducing subcutaneous fat by utilizing
the combination of ingredients. A fascia tissue treatment device,
as described in U.S. Patent Application No. 2014/0243718, can
include a bar and a plurality of flower-like or claw-shaped
element(s) connected to the bar along a plane. The flower-like
elements can each include multiple fingers that are stiff and
extend outward from the bar. Without being bound by theory, it is
believed that at least one of the ingredients in the oil described
herein work to induce thermogenic processes in the body for
cellulite and fat reducing effects during application and use of
fascia tissue treatment device. In particular, the oil composition
may increase .beta.-oxidation of fatty acids in adipocytes, thereby
burning accumulated fat. A dermatologically acceptable vehicle was
discovered that provides a stable environment for the active
ingredients while also providing lubrication for the fascia tissue
treatment device, and a pleasant scent and tactile property when
applied to skin. Because the use of the fascia tissue treatment
device can occur after showering, for example, the pleasant scent
avoids a common resistance of users of certain ingredients that
provide for burning accumulated subcutaneous fat due to unpleasant
odors.
[0012] The principles described herein relate to compositions for
reducing cellulite and affecting of the beauty conditions and body
fat while both lubricating skin for application of a fascia tissue
treatment device and having a pleasant odor. In one embodiment, the
composition includes the active ingredients caprylic/capric
triglyceride, plankton extract, and tocopherol. One source of such
active ingredients is, for example, Lipout.TM. by Provital Group,
Barcelona, Spain. Lipout is microalgae, Tisochrysis lutea, which is
standardized for xanthophylls and rich in polyunsaturated fatty
acids. Lipout may be used to activate a browning function of
adipocytes to sculpt the body and to reduce cellulite appearance
with improved firmness and elasticity. In particular embodiments,
to provide a satisfying and pleasant aroma in addition to adequate
lubrication for use with a fascia tissue treatment device, the
composition includes additional compounds in conjunction with
active ingredients. In some embodiments, the composition includes
sunflower seed oil, caprylic/capric triglyceride, rice bran
extract, plankton extract, rosemary leaf extract, sunflower
extract, tocopherol, isopropyl myristate, soybean seed oil,
lavender oil, lavendin oil, phenoxyethanol, caprylyl glycol,
ethylhexylglycerin, hexylene glycol, fragrance, or any combination
thereof. The compositions can include any number of combinations of
additional ingredients described throughout this specification. The
concentrations of the any ingredient within the compositions can
vary. In non-limiting embodiments, for example, the compositions
can comprise, consisting essentially of, or consist of, in their
final form, for example, about 0.01% to about 95.00% or any range
derivable therein, of at least one of the ingredients that are
mentioned throughout the specification and claims. The percentage
can be calculated by weight of the total composition. A person of
ordinary skill in the art would understand that the concentrations
can vary depending on the addition, substitution, and/or
subtraction of ingredients in a given composition.
[0013] The disclosed compositions can also include various
antioxidants to retard oxidation of one or more components.
Additionally, the prevention of the action of microorganisms can be
brought about by preservatives, such as various antibacterial and
antifungal agents. Further, the disclosed compositions can also
include cosmetic ingredients, UV absorption agents, moisturizing
agents, structuring agents, emulsifiers, thickening agents, and
pharmaceutical ingredients.
[0014] The disclosed compositions can be incorporated into all
types of formulations. Non-limiting examples of suitable
formulations include emulsions (e.g., water-in-oil,
water-in-oil-in-water, oil-in-water, silicone-in-water,
water-in-silicone, oil-in-water-in-oil, oil-in-water-in-silicone
emulsions), creams, lotions, solutions (both aqueous and
hydro-alcoholic), anhydrous bases (such as lipsticks and powders),
gels, and ointments or by other method or any combination of the
forgoing as would be known to one of ordinary skill in the art.
Variations and other appropriate formulations will be apparent to
the skilled artisan and are appropriate for use in the present
embodiment. In certain embodiments, it is important that the
concentrations and combinations of the compounds, ingredients, and
agents be selected in such a way that the combinations are
chemically compatible and do not form complexes which precipitate
from the finished product.
[0015] It is also contemplated that ingredients identified
throughout this specification, including but not limited to
caprylic/capric triglyceride, plankton extract, and tocopherol, or
any combinations thereof, can be individually or combinatorially
encapsulated for delivery to a target area such as skin.
Non-limiting examples of encapsulation techniques include the use
of liposomes, vesicles, and/or nanoparticles (e.g., biodegradable
and non-biodegradable colloidal particles comprising polymeric
materials in which the ingredient is trapped, encapsulated, and/or
absorbed) that can be used as delivery vehicles to deliver the
ingredient to skin. See, e.g., U.S. Pat. Nos. 6,387,398; 6,203,802;
and 5,411,744.
[0016] The principles described herein also relate to a process of
forming a composition to reduce cellulite and lubricate the skin
for application of a fascia tissue treatment device. In certain
embodiments, the process includes mixing sunflower seed oil,
caprylic/capric triglyceride, rice bran extract, plankton extract,
rosemary leaf extract, sunflower extract, tocopherol, isopropyl
myristate, soybean seed oil, lavender oil, lavendin oil,
phenoxyethanol, caprylyl glycol, ethylhexylglycerin, hexylene
glycol, fragrance, or any combination thereof.
[0017] Definitions and methods described herein are provided to
better define the present disclosure and to guide those of ordinary
skill in the art in the practice of the present disclosure. Unless
otherwise noted, terms are to be understood according to
conventional usage by those of ordinary skill in the relevant
art.
[0018] In some embodiments, numbers expressing quantities of
ingredients, properties such as molecular weight, reaction
conditions, and so forth, used to describe and claim certain
embodiments of the present disclosure are to be understood as being
modified in some instances by the term "about." In some
embodiments, the term "about" is used to indicate that a value
includes the standard deviation of the mean for the device or
method being employed to determine the value. In some embodiments,
the numerical parameters set forth in the written description and
attached claims are approximations that can vary depending upon the
desired properties sought to be obtained by a particular
embodiment. In some embodiments, the numerical parameters should be
construed in light of the number of reported significant digits and
by applying ordinary rounding techniques. Notwithstanding that the
numerical ranges and parameters setting forth the broad scope of
some embodiments of the present disclosure are approximations, the
numerical values set forth in the specific examples are reported as
precisely as practicable. The numerical values presented in some
embodiments of the present disclosure may contain certain errors
necessarily resulting from the standard deviation found in their
respective testing measurements. The recitation of ranges of values
herein is merely intended to serve as a shorthand method of
referring individually to each separate value falling within the
range. Unless otherwise indicated herein, each individual value is
incorporated into the specification as if it were individually
recited herein.
[0019] In some embodiments, the terms "a" and "an" and "the" and
similar references used in the context of describing a particular
embodiment (especially in the context of certain of the following
claims) can be construed to cover both the singular and the plural,
unless specifically noted otherwise. In some embodiments, the term
"or" as used herein, including the claims, is used to mean "and/or"
unless explicitly indicated to refer to alternatives only or the
alternatives are mutually exclusive.
[0020] The terms "comprise," "have" and "include" are open-ended
linking verbs. Any forms or tenses of one or more of these verbs,
such as "comprises," "comprising," "has," "having," "includes" and
"including," are also open-ended. For example, any method that
"comprises," "has" or "includes" one or more steps is not limited
to possessing only those one or more steps and can also cover other
unlisted steps. Similarly, any composition or device that
"comprises," "has" or "includes" one or more features is not
limited to possessing only those one or more features and can cover
other unlisted features.
[0021] All methods described herein can be performed in any
suitable order unless otherwise indicated herein or otherwise
clearly contradicted by context. The use of any and all examples,
or exemplary language (e.g., "such as") provided with respect to
certain embodiments herein is intended merely to better illuminate
the present disclosure and does not pose a limitation on the scope
of the present disclosure otherwise claimed. No language in the
specification should be construed as indicating any non-claimed
element essential to the practice of the present disclosure.
[0022] Groupings of alternative elements or embodiments of the
present disclosure disclosed herein are not to be construed as
limitations. Each group member can be referred to and claimed
individually or in any combination with other members of the group
or other elements found herein. One or more members of a group can
be included in, or deleted from, a group for reasons of convenience
or patentability. When any such inclusion or deletion occurs, the
specification is herein deemed to contain the group as modified
thus fulfilling the written description of all Markush groups used
in the appended claims.
[0023] All publications, patents, patent applications, and other
references cited in this application are incorporated herein by
reference in their entirety for all purposes to the same extent as
if each individual publication, patent, patent application or other
reference was specifically and individually indicated to be
incorporated by reference in its entirety for all purposes.
Citation of a reference herein shall not be construed as an
admission that such is prior art to the present disclosure.
[0024] Having described the present disclosure in detail, it will
be apparent that modifications, variations, and equivalent
embodiments are possible without departing the scope of the present
disclosure defined in the appended claims. Furthermore, it should
be appreciated that all examples in the present disclosure are
provided as non-limiting examples.
EXAMPLES
[0025] The following non-limiting examples are provided to further
illustrate the present disclosure. It should be appreciated by
those of skill in the art that the techniques disclosed in the
examples that follow represent approaches the inventors have found
function well in the practice of the present disclosure, and thus
can be considered to constitute examples of modes for its practice.
However, those of skill in the art should, in light of the present
disclosure, appreciate that many changes can be made in the
specific embodiments that are disclosed and still obtain a like or
similar result without departing from the spirit and scope of the
present disclosure.
Example 1
Compounds
[0026] Body fat, cellulite, and other beauty conditions can be
reduced by triggering the thermogenic processes within adipocytes
using the active ingredients caprylic/capric triglyceride, plankton
extract, and tocopherol optionally in conjunction with the
application of a fascia tissue treatment device. A composition
comprising sunflower seed oil, caprylic/capric triglyceride, rice
bran extract, plankton extract, rosemary leaf extract, sunflower
extract, tocopherol, isopropyl myristate, soybean seed oil,
lavender oil, lavendin oil, phenoxyethanol, caprylyl glycol,
ethylhexylglycerin, hexylene glycol, and fragrance can visibly
reduce the unsightly effects of cellulite on the skin following
repeated topical applications during use of a fascia tissue
treatment device.
[0027] The Composition can Include:
TABLE-US-00001 INCI Name Percent (wt/vol %) Helianthus annuus seed
oil 80.0-95.0 caprylic/capric triglyceride 5.0-10.0 Oryza sativa
bran extract 1.0-4.0 plankton extract 0.01-0.09 Rosmarinus
officinalis leaf extract 0.01-0.09 Helianthus annuus extract
0.1-0.9 Tocopherol 0.01-0.09 isopropyl myristate 0.1-0.9 Glycine
soja seed oil 0.1-0.9 Lavandula angustifolia oil 0.01-0.09
Lavandula hybrida oil 0.01-0.09 Phenoxyethanol 0.1-0.9 caprylyl
glycol 0.1-0.9 Ethylexylglycerin 0.01-0.09 hexylene glycol
0.01-0.09 Fragrance 0.1-0.9 Total 100.00
Example 2
Compound Preparation
[0028] To prepare a dermatologically acceptable vehicle that
provides a chemically stable and cosmetically acceptable
environment for the ingredients capable of reducing cellulite,
impacting other beauty conditions, and lubricating the skin during
an optional usage or application of a fascia tissue treatment
device, caprylic/capric triglyceride, plankton extract, and
tocopherol can be mixed with sunflower seed oil, rice bran extract,
rosemary leaf extract, sunflower extract, isopropyl myristate,
soybean seed oil, lavender oil, lavendin oil, phenoxyethanol,
caprylyl glycol, ethylhexylglycerin, hexylene glycol, and
fragrance.
[0029] The amount of each ingredient can vary. For example, the
composition can include sunflower seed oil from about 80.0% to
about 95.0%; caprylic/capric triglyceride from about 5.0% to about
10.0%; rice bran extract from about 1.0% to about 4.0%; plankton
extract from about 0.01% to about 0.09%; rosemary leaf extract from
about 0.01% to about 0.09%; sunflower extract from about 0.1% to
about 0.9%; tocopherol from about 0.01% to about 0.09%; isopropyl
myristate from about 0.1% to about 0.9%; soybean seed oil from
about 0.1% to about 0.9%; lavender oil from about 0.01% to about
0.09%; lavendin oil from about 0.01% to about 0.09%; phenoxyethanol
from about 0.1% to about 0.9%; caprylyl glycol from about 0.1% to
about 0.9%; ethylhexylglycerin from about 0.01% to about 0.09%;
hexylene glycol from about 0.01% to about 0.09%; and fragrance from
about 0.1% to about 0.9% of the total weight by volume, of the
entire composition.
[0030] As various modifications could be made in the compositions
and methods herein described without departing from the scope of
the invention, it is intended that all matter contained in the
foregoing description shall be interpreted as illustrative rather
than limiting. The breadth and scope of the present invention
should not be limited by any of the above-described exemplary
embodiments, but should be defined only in accordance with the
following claims appended hereto and their equivalents. All patent
and non-patent documents cited in this specification are
incorporated herein by reference in their entireties.
* * * * *